Loading...
•
Sep 28, 2024
Masimo Q3 2024 Earnings Report
Masimo reported strong third quarter performance, driven by the healthcare segment.
Key Takeaways
Masimo Corporation announced financial results for the third quarter ended September 28, 2024. Consolidated revenue was $504.6 million, with healthcare revenue at $343.3 million and non-healthcare revenue at $161.3 million. GAAP net income per diluted share was $0.18, while non-GAAP net income per diluted share was $0.98.
Healthcare revenue of $343.3 million increased 11.5% on a reported basis.
GAAP net income per diluted share was $0.18.
Non-GAAP net income per diluted share was $0.98.
Shipments of noninvasive technology boards and instruments were 60,500.
Forward Guidance
The Company provided the following non-GAAP estimates for its fourth quarter 2024 and updated full-year 2024 guidance.
Positive Outlook
- Consolidated revenue $581 to $611 million for Q4 2024
- Healthcare revenue $363 to $373 million for Q4 2024
- Non-healthcare revenue $218 to $238 million for Q4 2024
- Non-GAAP operating income $103 to $114 million for Q4 2024
- Non-GAAP earnings per diluted share $1.35 to $1.50 for Q4 2024
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...